Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Virology

• Publication date

  1992-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.66.1.325-333.1992PMID 1309249PMCID PMC238291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Papillomaviruses in human cancers

  1999cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• Critical structural elements of the VP16 transcriptional activation domain.

  1991cited by this paper
• Reduced binding of TFIID to transcriptionally compromised mutants of VP16

  1991cited by this paper
• The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

  1991cited by this paper
• Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.

  1991cited by this paper
• Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.

  1991cited by this paper
• Several different upstream promoter elements can potentiate transactivation by the BPV‐1 E2 protein.

  1991cited by this paper
• Mechanism of action of an acidic transcriptional activator in vitro.

  1991cited by this paper
• Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance

  1990cited by this paper
• Site-specific mutagenesis using asymmetric polymerase chain reaction and a single mutant primer.

  1990cited by this paper
• Association of human papillomavirus types 16 and 18 E6 proteins with p53.

  1990cited by this paper
• Presence of a potent transcription activating sequence in the p53 protein.

  1990cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• Transcription factor LSF binds two variant bipartite sites within the SV40 late promoter.

  1990cited by this paper
• Mechanism of transcriptional activation by Sp1: evidence for coactivators.

  1990cited by this paper
• Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein.

  1990cited by this paper
• A potential transcriptional activation element in the p53 protein.

  1990cited by this paper
• Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells

  1990cited by this paper
• Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

  1989cited by this paper
• Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7

  1989cited by this paper
• Papillomavirus polypeptides E6 and E7 are zinc-binding proteins

  1989cited by this paper
• Intracellular localization and DNA-binding properties of human papillomavirus type 18 E6 protein expressed with a baculovirus vector

  1989cited by this paper
• The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes

  1989cited by this paper
• Mechanisms of viral-mediated trans-activation of transcription.

  1989cited by this paper
• Heterogeneity of the human papillomavirus group

  1989cited by this paper
• HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

  1989cited by this paper
• Mutational analysis of bovine papillomavirus E6 gene

  1989cited by this paper
• A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs

  1988cited by this paper
• Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID

  1988cited by this paper
• Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18

  1988cited by this paper
• Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells.

  1988cited by this paper
• Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA

  1987cited by this paper
• Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

  1987cited by this paper
• Isolation of RNA using guanidinium salts.

  1987cited by this paper
• Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors

  1987cited by this paper
• Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines

  1987cited by this paper
• DNA-binding activity of papillomavirus proteins

  1987cited by this paper
• CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements

  1987cited by this paper
• Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.

  1987cited by this paper
• Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

  1986cited by this paper
• Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells

  1986cited by this paper
• The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

  1985cited by this paper
• Bovine papillomavirus contains multiple transforming genes.

  1985cited by this paper
• Vector expression of adenovirus type 5 E1a proteins: evidence for E1a autoregulation.

  1985cited by this paper
• Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

  1985cited by this paper
• An enhancer-like element in the adenovirus E2 promoter contains sequences essential for uninduced and E1A-induced transcription.

  1985cited by this paper
• Identification of a second transforming region in bovine papillomavirus DNA.

  1984cited by this paper
• High efficiency gene transfer into mammalian cells.

  1984influential reference
• The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter.

  1983cited by this paper
• A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

  1983cited by this paper
• Transcriptional control signals of a eukaryotic protein-coding gene.

  1982cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper

• A Novel Method for Predicting Oncogenic Types of Human Papillomavirus

  2025cites this paper
• Integrative Analysis of Shared Pathogenic Genes and Potential Mechanisms in Gardnerella vaginalis and Persistent HPV16 Infection

  2025cites this paper
• The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model

  2020cites this paper
• Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression

  2020cites this paper
• Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

  2019cites this paper
• Retraction Note: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

  2019cites this paper
• Détection moléculaire des métastases des ganglions lymphatique dans le cancer du col de l'utérus

  2015cites this paper
• A study of PDZ protein expression during the human papillomavirus life cycle

  2015cites this paper
• Inactivation of p53 Rescues the Maintenance of High Risk HPV DNA Genomes Deficient in Expression of E6

  2013cites this paper
• Silencing of multi-copy HPV16 by viral self-methylation and chromatin occlusion: a model for epigenetic virus-host interaction.

  2012cites this paper
• Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration.

  2011cites this paper
• Characterization of a cluster of oncogenic mutations in E6 of a human papillomavirus 83 variant isolated from a high-grade squamous intraepithelial lesion.

  2011cites this paper
• IL-10 expression is regulated by HPV E2 protein in cervical cancer cells.

  2011cites this paper
• RNA de interferencia: biogénesis, mecanismos moleculares y sus aplicaciones en cáncer cervical

  2010cites this paper
• [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].

  2010cites this paper
• Viral Oncogenes, Noncoding RNAs, and RNA Splicing in Human Tumor Viruses

  2010cites this paper
• RNA de interferencia: biogénesis, mecanismos moleculares y sus aplicaciones en cáncer cervical

  2010cites this paper
• International Journal of Biological Sciences

  2009cites this paper
• Review Article Infection and Cervical Neoplasia: Facts and Fiction

  2009cites this paper
• The role of the ubiquitin proteasome pathway in papillomavirus pathogenicity

  2009cites this paper
• Infection and cervical neoplasia: facts and fiction.

  2009cites this paper
• Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.

  2009cites this paper
• DNA vaccine encoding endosome‐targeted human papillomavirus type 16 E7 protein generates CD4+ T cell‐dependent protection

  2007cites this paper
• Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and modulation of apoptosis

  2006cites this paper
• Effects of human papillomavirus type 16 oncoproteins on survivin gene expression.

  2006cites this paper
• E6 and E7 Oncoproteins from Human Papillomavirus Type 16 Induce Activation of Human Transforming Growth Factor β 1 Promoter throughout Sp1 Recognition Sequence

  2006cites this paper
• Dissection of the Interplay Between HPV E6 and Its Cellular and Viral Targets

  2005cites this paper
• Constitutive activation of transcription factor AP‐1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP‐1 activity in HeLa cells by curcumin

  2005cites this paper
• Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors

  2004cites this paper
• Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells

  2004cites this paper
• Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.

  2004cites this paper
• Regulation of cell cycle progression and apoptosis by the papillomavirus E6 oncogene.

  2004cites this paper
• Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-β2 (TGF-β2) promoter

  2004cites this paper
• A Genomic Approach Reveals a Novel Mitotic Pathway in Papillomavirus Carcinogenesis

  2004cites this paper
• The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1.

  2003cites this paper
• Signals That Dictate Nuclear Localization of Human Papillomavirus Type 16 Oncoprotein E6 in Living Cells

  2003cites this paper
• Repression of HPV E6-activated RSV promoter activity by anti-cancer agents.

  2003cites this paper
• The human papillomavirus type 11 and 16 E 6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br 1

  2003influential citation
• SignalsThat Dictate Nuclear Localization of Human Papillomavirus Type 16Oncoprotein E6 in LivingCells

  2003cites this paper
• Fusion of a tumour-associated antigen to HIV-1 Tat improves protein-based immunotherapy of cancer.

  2003cites this paper
• Interaction of Papillomaviral Oncoproteins with Cellular Factors

  2002cites this paper
• Expression of the potential novel gene E6DG1 downregulated by the E6 protein of human papillomavirus type 16 is correlated with anchorage-independent growth.

  2002cites this paper
• Replication-Selective Herpes Simplex Virus Type 1 Mutant Therapy of Cervical Cancer Is Enhanced by Low-Dose Radiation

  2002cites this paper
• Clinical Value of Thymidine Kinase in Patients with Cervical Carcinoma

  2001cites this paper
• Laimins GC-Rich Sp 1 Binding Sites Transcriptase Expression through Myc and Induction of Human Telomerase Reverse Papillomavirus Type 16 E 6 Protein : Telomerase Activation by Human

  2001cites this paper
• Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites

  2001cites this paper
• The Human Papillomavirus E6 protein and its contribution to malignant progression

  2001cites this paper
• Biology of human papillomaviruses

  2001cites this paper
• Virus-associated human tumors: cervical carcinomas and papilloma viruses.

  2000cites this paper
• Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

  2000cites this paper
• Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner

  2000cites this paper
• Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins.

  2000cites this paper
• The Possible Role of Chemokines in HPV-Linked Carcinogenesis

  1999cites this paper
• Pleiotropic effects of human papillomavirus type 16 E6 oncogene expression in human epithelial cell lines.

  1999cites this paper
• Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.

  1998cites this paper
• Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6

  1998cites this paper
• The papillomavirus E6 proteins.

  1998cites this paper
• Trans-activating activity of the E6 proteins of the human papillomavirus (HPV) type-11 and -16 on the PE1E4 promoter of HPV-11 in C33A cells.

  1998cites this paper
• The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms.

  1998cites this paper
• Interaction of Human Papillomavirus 8 Regulatory Proteins E2, E6 and E7 with Components of the TFIID Complex

  1998cites this paper
• Human papillomaviruses and cervical cancer.

  1997cites this paper
• Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein.

  1997cites this paper
• Human papillomavirus type 16 E6 protein transcriptionally modulates fibronectin gene expression by induction of protein complexes binding to the cyclic AMP response element

  1997influential citation
• Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription

  1997cites this paper
• Papillomvirusassoziierte Erkrankungen bei HIV-positiven Patienten

  1997cites this paper
• Regulation of E6 and E7 Oncogene Transcription

  1997cites this paper
• Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.

  1997cites this paper
• HPV16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence.

  1997cites this paper
• Transactivation of Prothymosin α and c-mycPromoters by Human Papillomavirus Type 16 E6 Protein

  1997cites this paper
• Short Communication Telomerase Activation inCervical Cancer

  1997cites this paper
• Telomerase activation in cervical cancer.

  1997cites this paper
• Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis

  1997cites this paper
• The oncogenic role of human papillomavirus proteins.

  1996cites this paper
• Bovine papillomavirus type 4.

  1996cites this paper
• The molecular pharmacology of ovarian steroid receptors.

  1996cites this paper
• Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors

  1996cites this paper
• Human papillomavirus type 16 E6 protein up-regulates the expression of the high mobility group protein HMG-I(Y) gene in mouse 10T1/2 cells.

  1996cites this paper
• Transforming activity of the E6 gene of HPV-11gt in NIH 3T3 and REF 52 cells: correlation with the level of E6 transcription.

  1996cites this paper
• Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16

  1996cites this paper
• p53-Dependent and -independent transactivation by the E6 protein of human papillomavirus type 16.

  1996cites this paper
• Mechanism of HPV E6 proteins in cellular transformation.

  1996cites this paper
• DNA Tumor Viruses

  1995influential citation
• Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer.

  1995cites this paper
• The E 6 Protein

  1995influential citation
• Human Papillomavirus E6 and E7: Proteins which deregulate the cell cycle

  1995cites this paper
• Papillomaviruses as Promoting Agents in Human Epithelial Tumors

  1995cites this paper
• The structure, function, and regulation of papillomaviral genes in infection and cervical cancer.

  1994cites this paper
• The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53.

  1994cites this paper
• Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60.

  1994cites this paper
• A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1.

  1994cites this paper
• Cell cycle checkpoint control is bypassed by human papillomavirus oncogenes.

  1994cites this paper
• Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16.

  1994cites this paper
• Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells.

  1994cites this paper
• Transforming proteins of the papillomaviruses.

  1994cites this paper
• Modulation of transcriptional regulatory properties of p53 by HPV E6.

  1994cites this paper
• The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest

  1994cites this paper
• Correlation between Tumorigenicity and Expression Levels or Splicing Patterns of Transcripts of the Human Papillomavirus Type 16 E6 Gene

  1994cites this paper
• Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia.

  1994cites this paper
• Molecular biology of human papillomavirus infection and oncogenesis.

  1994cites this paper
• Cellular transformation by papilomavirus oncorproteins

  1993cites this paper